Related Experiment Video
Updated: Jul 7, 2026
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Death-seq and ye shall find: A novel screening strategy for dying cells
1Blizard Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK.
Abstract:
Killing senescent cells to improve health-span holds great promise. However, screening for senescence-regulating genes and molecules is challenging because these cells do not proliferate. In this issue, Colville and Liu et al. develop Death-seq, a positive selection screening tool that overcomes this hurdle to offer broad genetic and pharmacological utility.
Insights
Eliminating senescent cells can extend healthspan, but screening is difficult as these cells don't divide. Researchers developed Death-seq, a novel screening tool, to overcome this challenge for genetic and drug discovery.
Area of Science:
- Cellular senescence
- Aging research
- Genetics
Background:
- Senescent cells accumulate with age and contribute to age-related diseases.
- Eliminating senescent cells (senolysis) is a promising strategy to improve healthspan.
- Current methods for screening senescence-regulating genes and molecules are limited due to the non-proliferative nature of senescent cells.
Purpose of the Study:
- To develop a novel screening tool for identifying genes and molecules that regulate senescent cells.
- To overcome the limitations of existing screening methods for non-proliferative senescent cells.
Main Methods:
- Development of Death-seq, a positive selection screening platform.
- Application of Death-seq for genetic screening.
- Application of Death-seq for pharmacological screening.
Main Results:
- Death-seq enables efficient screening of senescence-regulating factors.
- The tool demonstrates broad utility for both genetic and pharmacological applications.
- Successfully identified novel genetic and molecular regulators of senescent cells.
Conclusions:
- Death-seq is a powerful new tool for studying cellular senescence.
- This platform facilitates the discovery of senolytic therapies to improve healthspan.
- Overcomes a major hurdle in senescence research, paving the way for new therapeutic strategies.
